Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 19
1989 90
1990 151
1991 186
1992 197
1993 329
1994 432
1995 556
1996 716
1997 893
1998 1058
1999 1223
2000 1412
2001 1424
2002 1408
2003 1432
2004 1422
2005 1679
2006 1855
2007 1955
2008 2103
2009 2225
2010 2296
2011 2513
2012 2532
2013 2787
2014 2749
2015 2694
2016 2328
2017 2225
2018 1948
2019 1034
2020 30
Text availability
Article attribute
Article type
Publication date

Search Results

41,491 results
Results by year
Filters applied: . Clear all
Page 1
Structural Analysis of Chemokine Receptor-Ligand Interactions.
Arimont M, Sun SL, Leurs R, Smit M, de Esch IJP, de Graaf C. Arimont M, et al. J Med Chem. 2017 Jun 22;60(12):4735-4779. doi: 10.1021/acs.jmedchem.6b01309. Epub 2017 Mar 10. J Med Chem. 2017. PMID: 28165741 Free PMC article. Review.
Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3.
Heuninck J, Perpiñá Viciano C, Işbilir A, Caspar B, Capoferri D, Briddon SJ, Durroux T, Hill SJ, Lohse MJ, Milligan G, Pin JP, Hoffmann C. Heuninck J, et al. Mol Pharmacol. 2019 Dec;96(6):778-793. doi: 10.1124/mol.118.115477. Epub 2019 May 15. Mol Pharmacol. 2019. PMID: 31092552 Review.
Proteolytic control of Interleukin-11 and Interleukin-6 biology.
Lokau J, Agthe M, Flynn CM, Garbers C. Lokau J, et al. Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt B):2105-2117. doi: 10.1016/j.bbamcr.2017.06.008. Epub 2017 Jun 16. Biochim Biophys Acta Mol Cell Res. 2017. PMID: 28630024 Free article. Review.
CD25 gene polymorphism and multiple sclerosis.
Alsahebfosoul F, Salehi R, Ghaffari S, Jahanbani-Ardakani H, Etemadifar M, Kazemi M, Abtahi SH. Alsahebfosoul F, et al. Mult Scler Relat Disord. 2017 Nov;18:117-118. doi: 10.1016/j.msard.2017.09.005. Epub 2017 Sep 20. Mult Scler Relat Disord. 2017. PMID: 29141792 No abstract available.
Novel activating mutations lacking cysteine in type I cytokine receptors in acute lymphoblastic leukemia.
Shochat C, Tal N, Gryshkova V, Birger Y, Bandapalli OR, Cazzaniga G, Gershman N, Kulozik AE, Biondi A, Mansour MR, Twizere JC, Muckenthaler MU, Ben-Tal N, Constantinescu SN, Bercovich D, Izraeli S. Shochat C, et al. Blood. 2014 Jul 3;124(1):106-10. doi: 10.1182/blood-2013-10-529685. Epub 2014 May 1. Blood. 2014. PMID: 24787007 Free article.
Prognostic value of DcR3 in solid tumors: A meta-analysis.
Ge H, Liang C, Ren S, Yue C, Wu J. Ge H, et al. Clin Chim Acta. 2018 Jun;481:126-131. doi: 10.1016/j.cca.2018.02.038. Epub 2018 Feb 28. Clin Chim Acta. 2018. PMID: 29499202
CXCR4 and CCR7: Two eligible targets in targeted cancer therapy.
Mishan MA, Ahmadiankia N, Bahrami AR. Mishan MA, et al. Cell Biol Int. 2016 Sep;40(9):955-67. doi: 10.1002/cbin.10631. Epub 2016 Jul 22. Cell Biol Int. 2016. PMID: 27248053 Review.
41,491 results
Jump to page
Feedback